NCT05145686View on ClinicalTrials.gov

The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

December 1, 2019

Conditions
Reversible Pulpitis
Interventions
DIAGNOSTIC_TEST

Matris metalloproteinase -2, -8, -9 expressions

. The aims of this in vivo study was to compare the expression levels of MMP-2, -8 and -9 in primary molars with reversible and irreversible pulpitis and to compare the clinically and radiographically success of MTA and Biodentine materials at the end of 18 months.

Trial Locations (1)

35040

Ege University, Izmir

All Listed Sponsors
lead

Ege University

OTHER

NCT05145686 - The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments | Biotech Hunter | Biotech Hunter